Site Menu
Buscar Close Search
Buscar Close Search
Page Menu

Roger J. Davis, PhD

Research Focus - Stress Signaling and Cancer

  • Stress signaling as a contributor to tumor development and a therapeutic target
  • The actions of stress signaling in both tumor cells and the tumor microenvironment
  • The capacity of stress signaling to drive tumor-associated inflammation
  • The role of obesity-associated stress signaling in the promotion of tumor development

Representative Publication

Girnius N, Edwards YJK, Garlick DS, Davis RJ.  The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation. eLife. 2018;7:e36389.

Read Publication

More Publications

In the News

Getting Results…
  • Phillip Zamore, Roger Davis elected to National Academy of Medicine

    Phillip Zamore, Roger Davis elected to National Academy of Medicine

    UMass Chan Medical School scientists Phillip D. Zamore, PhD, and Roger J. Davis, PhD, FRS, were elected to the National Academy of Medicine on Oct. 9 for their distinguished contributions to medicine and health.

    Read more
  • UMass Medical School receives $2.8 million grant for advanced cryo-EM microscope

    UMass Medical School receives $2.8 million grant for advanced cryo-EM microscope

    Roger Davis, PhD, FRS, and the Cryo-EM Core facility at UMass Medical School have received $2.8 million from The Massachusetts Life Sciences Center to purchase an advanced Glacios cryo-electron microscope from Thermo Fisher Scientific.

    Read more
  • Roger Davis elected to American Academy of Arts & Sciences

    Roger Davis elected to American Academy of Arts & Sciences

    Roger J. Davis, PhD, FRS, has been elected a member of the American Academy of Arts & Sciences in recognition of his research on stress signaling pathways that are connected to a range of diseases, such as arthritis, cancer, stroke, heart disease and diabetes.

    Read more
  • Roger Davis to chair Program in Molecular Medicine

    Roger Davis to chair Program in Molecular Medicine

    Roger J. Davis, PhD, FRS, has accepted the position of chair of the Program in Molecular Medicine, succeeding Michael P. Czech, PhD, the founding chair.

    Read more